Grünenthal GmbH (CEO: Gabriel Baertschi), a global, science-based, privately-owned pharmaceutical company and Kyowa Kirin Co., Ltd., (TSE:4151, President and CEO: Masashi Miyamoto, Kyowa Kirin), a …
/PRNewswire/ Grünenthal GmbH (CEO: Gabriel Baertschi), a global, science-based, privately-owned pharmaceutical company and Kyowa Kirin Co., Ltd., (TSE:4151,.
Kyowa Kirin Co., Ltd. hereby announces that Kyowa Kirin International plc, a subsidiary of the Company, has signed a Joint Venture Collaboration agreement with Grunenthal GmbH for the established. | November 25, 2022
The Joint Venture Collaboration includes a portfolio of 13 life-changing brands across six therapeutic areas, with revenues primarily resulting from pain management medicines The collaboration